Skip Navigation


NDT Advance Access originally published online on February 19, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/5/1092    most recent
gfh107v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schrijvers, B. F.
Right arrow Articles by Flyvbjerg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schrijvers, B. F.
Right arrow Articles by Flyvbjerg, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2004) 19: 1092-1097
Nephrol Dial Transplant Vol. 19 No. 5 © ERA-EDTA 2004; all rights reserved


Original Article

Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes

Bieke F. Schrijvers1,3, An S. De Vriese3,5, Johan Van de Voorde4, Ruth Rasch2, Norbert H. Lameire3 and Allan Flyvbjerg1

1Medical Research Laboratories, Institute of Experimental Clinical Research, Aarhus University Hospital, 2Department of Cell Biology, Institute of Anatomy, Aarhus University, Aarhus, Denmark, 3Renal Unit, Department of Internal Medicine, Gent University Hospital, 4Department of Physiology and Physiopathology, Gent University, Gent and 5Renal Unit, Department of Internal Medicine, AZ Sint-Jan AV, Brugge, Belgium

Correspondence and offprint requests to: Bieke Schrijvers, Renal Unit, Gent University Hospital, Gent, Belgium. Email: Bieke.Schrijvers{at}UGent.be

Background. Type 2 diabetes has become the single most frequent cause of end-stage renal disease. The Goto–Kakizaki rat is currently used as a model for lean type 2 diabetes, but its renal changes have not been fully characterized. We investigated long-term functional and structural renal changes in the Goto–Kakizaki rat to evaluate if this animal model resembles the changes observed in human diabetic kidney disease.

Methods. Urinary albumin excretion, creatinine clearance and blood pressure were measured at the age of 2, 8 and 14 months in 12 female Goto–Kakizaki rats and 10 female, non-diabetic Wistar rats. To study kidney morphology, kidney weight, glomerular volume, basement membrane thickness, mesangial fraction and total mesangial volume were determined at 14 months.

Results. Urinary albumin excretion rose progressively over time in both groups, but was significantly higher in Goto–Kakizaki rats than in Wistar rats. Creatinine clearance decreased over time in Goto–Kakizaki rats but not in Wistar rats. Blood pressure was in the normotensive range in all animals throughout the study. Kidney weight, glomerular volume, basement membrane thickness, mesangial fraction and total mesangial volume were significantly higher in Goto–Kakizaki rats than in Wistar rats. Body weight and blood glucose levels were higher, whereas serum insulin levels were not different or lower in Goto–Kakizaki rats compared with Wistar rats.

Conclusion. The Goto–Kakizaki rat is a lean, hyperglycaemic, euinsulinaemic, normotensive experimental model of type 2 diabetes with robust functional and structural renal changes.

Keywords: albuminuria; basement membrane thickness; glomerular volume; Goto–Kakizaki rat; kidney; mesangium


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
M. A. Nobrega, L. C. Solberg Woods, S. Fleming, and H. J. Jacob
Distinct genetic regulation of progression of diabetes and renal disease in the Goto-Kakizaki rat
Physiol Genomics, September 1, 2009; 39(1): 38 - 46.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. Herbach, I. Schairer, A. Blutke, S. Kautz, A. Siebert, B. Goke, E. Wolf, and R. Wanke
Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F819 - F829.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
V. Portik-Dobos, A. K. Harris, W. Song, J. Hutchinson, M. H. Johnson, J. D. Imig, D. M. Pollock, and A. Ergul
Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R435 - R441.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.